RecruitingNCT07312409

Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID?


Sponsor

York University

Enrollment

30 participants

Start Date

Jun 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

Millions have developed Long COVID (LC), and recent findings show an association between taurine deficiency (an amino acid) and symptoms in LC. Cost-effective and accessible interventions are needed to improve welfare and reduce healthcare costs. We will investigate the efficacy of 12-weeks of taurine supplementation (self-administered), on vascular function and the cardio/cerebrovascular responses to upright posture. We will measure resting vascular function with an EndoPAT device, resting heart rate variability, and the blood pressure, heart rate, and brain blood flow responses to 5 minutes of head-up tilt before and after weeks of taurine supplementation in LC. We hypothesize that the 12 weeks of supplementation will improve both resting vascular function and the responses to upright tilt. In turn, we hypothesize that symptoms will also improve (as measured by questionnaires).


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria1

  • Participants will have had symptoms of Long COVID post-infection for at least 3 months

Exclusion Criteria4

  • Inability to undergo tilt table testing for 5 minutes
  • Inability to transport selves to York University from their homes
  • Inability to speak English, or provide a translator
  • Blood clotting disorders

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTTaurine supplementation

Participants will self-administer 12-wks taurine supplementation


Locations(1)

York University

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07312409


Related Trials